PC-3 cells with HMMR stably overexpressing were used to construct the subcutaneous xenograft model [23], and the inhibitor of mTOCR2/AKT axis (Rapamycin:10 mg/kg) was used to treat the tumour-bearing mice [32]. Here, AKT1 is linked to neoplasm.